CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.2000
0.00 (0.00%)
Aug 18, 2026, 3:50 PM EST
CytoDyn Market Cap
CytoDyn has a market cap or net worth of $269.51 million as of August 19, 2026. Its market cap has decreased by -21.83% in one year.
Market Cap
269.51M
Enterprise Value
282.68M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.20
ChartMarket Cap Chart
Since November 17, 2005, CytoDyn's market cap has increased from 5.54M to 269.51M, an increase of 4,767.03%. That is a compound annual growth rate of 20.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 269.51M | -24.21% |
| Dec 31, 2025 | 355.63M | 164.14% |
| Dec 31, 2024 | 134.63M | -29.42% |
| Dec 29, 2023 | 190.74M | 2.63% |
| Dec 30, 2022 | 185.85M | -72.64% |
| Dec 31, 2021 | 679.28M | -78.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 848.95M |
| Northwest Biotherapeutics | 308.07M |
| Glorywin Entertainment Group | 182.41M |
| Vaxart | 120.22M |
| NDT Pharmaceuticals | 104.51M |
| HST Global | 91.93M |
| Sangamo Therapeutics | 66.08M |
| Arch Biopartners | 54.15M |